Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Rebecca A. Brachman"'
Autor:
Christina T. LaGamma, William W. Tang, Ashlea A. Morgan, Josephine Cecelia McGowan, Rebecca A. Brachman, Christine A. Denny
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 11 (2018)
Ketamine has been found to have rapid, long-lasting antidepressant effects in treatment-resistant (TR) patients with major depressive disorder (MDD). Recently, we have also shown that ketamine acts as a prophylactic to protect against the development
Externí odkaz:
https://doaj.org/article/cade3c66031a49a2b5f3c3db65759f7f
Autor:
Briana K. Chen, Donald W. Landry, Shi-Xian Deng, Xiaoming Xu, Christine A. Denny, Denis J. David, Victor M. Luna, Christina T LaGamma, Indira Mendez-David, Rebecca A. Brachman, Alain M. Gardier, Abhishek Shah, Thomas B. Cooper, Raymond F. Suckow
Publikováno v:
Neuropsychopharmacology
Enhancing stress resilience in at-risk populations could significantly reduce the incidence of stress-related psychiatric disorders. We have previously reported that the administration of (R,S)-ketamine prevents stress-induced depressive-like behavio
Autor:
Jose L. Garrido, Matías A. Medina, Felipe Bravo, Sarah McGee, Francisco Fuentes-Villalobos, Mario Calvo, Yazmin Pinos, James W. Bowman, Christopher D. Bahl, Maria Ines Barria, Rebecca A. Brachman, Raymond A. Alvarez
Publikováno v:
Cell reports. 39(9)
Despite SARS-CoV-2 being a "novel" virus, early detection of anti-spike IgG in severe COVID-19 patients may be caused by the amplification of humoral memory responses against seasonal coronaviruses. Here, we examine this phenomenon by characterizing
Autor:
Jose L. Garrido, Matias Medina, Felipe Bravo, Sarah McGee, Francisco Fuentes, Mario Calvo, James W. Bowman, Christopher D. Bahl, Maria Inés Barría, Rebecca A. Brachman, Raymond A. Alvarez
Despite SARS-CoV-2 being a “novel” coronavirus, several studies suggest that detection of anti-spike IgG early in infection may be attributable to the amplification of humoral memory responses against seasonal hCoVs in severe COVID-19 patients. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9026d7df2c13aac319f6b4cd4554cea
https://doi.org/10.1101/2021.09.14.460338
https://doi.org/10.1101/2021.09.14.460338
Autor:
Thomas B. Cooper, Xiaoming Xu, Raymond F. Suckow, Rebecca A. Brachman, Shi-Xian Deng, Donald W. Landry, Briana K. Chen, Christine A. Denny, Christina T. LaGamma
BACKGROUNDFemales are more likely than males to develop major depressive disorder (MDD) after exposure to stress. We previously reported that the administration of (R,S)-ketamine before stress can prevent stress-induced depressive-like behavior in ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5263d19a46b0837bf0fc338436096d
Autor:
Josephine C. McGowan, Alain M. Gardier, Sean C. Lim, Jennifer N. Perusini, Christine A. Denny, Thu Ha Pham, René Hen, Denis J. David, Charlène Faye, Indira Mendez-David, Rebecca A. Brachman
Publikováno v:
ResearcherID
Background Stress exposure is one of the greatest risk factors for psychiatric illnesses like major depressive disorder and posttraumatic stress disorder. However, not all individuals exposed to stress develop affective disorders. Stress resilience,
Autor:
Rebecca A. Brachman, Alessia Mastrodonato, Christina T. LaGamma, Christine A. Denny, Alfred J. Robison, Ina Pavlova, Randy Martinez
Background We previously reported that a single injection of ketamine prior to stress protects against the onset of depressive-like behavior and attenuates learned fear. However, the molecular pathways and brain circuits underlying ketamine-induced s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f3049d6a6dd5d68f05b4a203629500
https://europepmc.org/articles/PMC6107435/
https://europepmc.org/articles/PMC6107435/
Autor:
Rebecca A. Brachman, Christine A. Denny, Alessia Mastrodonato, Alexander Kitayev, Niven R. Narain, Michael A. Kiebish, Christina T. LaGamma, Josephine C. McGowan, Collin Hill
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 43(9)
Recently, we have shown that ketamine given prior to stress exposure protects against the development of depressive-like behavior in mice. These data suggest that it may be possible to prevent the induction of affective disorders before they develop
Autor:
Yuval Neria, Rebecca A. Brachman, Sean C. Lim, Melina Tsitsiklis, Josephine C. McGowan, Christine A. Denny, Christina T. LaGamma
Ketamine has been reported to be an efficacious antidepressant for major depressive disorder and posttraumatic stress disorder. Most recently, ketamine has also been shown to be prophylactic against stress-induced depressive-like behavior in mice. It
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f291b8fdd26f8ffa6a128292df78cd5d
https://europepmc.org/articles/PMC5518899/
https://europepmc.org/articles/PMC5518899/
Autor:
Alain M. Gardier, Rebecca A. Brachman, Christine A. Denny, Céline Defaix, Donald W. Landry, Shi-Xian Deng, Thu Ha Pham, Jean-Claude Alvarez, Nicolas Fabresse, Xiaoming Xu
Publikováno v:
Biological psychiatry. 84(1)